Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 31Neoplasms 8Neoplasm Metastasis 8Brain Neoplasms 5Prostatic Neoplasms 4Ovarian Neoplasms 4Glioma 4Endometrial Neoplasms 4Triple Negative Breast Neoplasms 3Neoplasms by Site 3Breast Diseases 3Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Meningioma 2Liposarcoma 2Head and Neck Neoplasms 2Glioblastoma 2Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Sarcoma, Ewing 1Sarcoma 1Recurrent Ovarian High Grade Serous Adenocarcinoma 1Pathologic Complete Response 1Pancreatic Neoplasms 1Neurofibromatosis 1 1Neoplasms, Squamous Cell 1Neoplasm, Residual 1

Interventions

pomalidomide 2plerixafor 1liposomal doxorubicin 1abemaciclib 1Watchful Waiting 1Transurethral Resection of Prostate 1Self Care 1Nivolumab 1Maraviroc 1Focus Groups 1Benzethonium 1Acetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × abemaciclib × 90 days × Clear all
NCT04941274 2026-05-05

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Recruiting
111 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡